Cellosaurus SaOS-2 (CVCL_0548)

Cell line name SaOS-2
Synonyms SAOS-2; Saos-2; SAOS 2; Saos 2; Saos2; SaOs2; SAOS2; Sarcoma OSteogenic-2; SaOS; SAOS
Accession CVCL_0548
Resource Identification Initiative To cite this cell line use: SaOS-2 (RRID:CVCL_0548)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
From: Memorial Sloan-Kettering Cancer Center; New York; USA.
Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 771.
Doubling time: ~43 hours (DSMZ).
Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).
Sequence variation: Homozygous for a TP53 deletion (PubMed=2823272).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Disease Osteosarcoma (NCIt: C9145)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children: CVCL_KU47 (Saos-2 Tet-Off); CVCL_X642 (SAOS-alpha2beta1); CVCL_9563 (SaOS-LM1); CVCL_9U47 (Saos2-I)
Sex of cell Female
Category Cancer cell line
STR profile Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; PubMed=11416159; RCB; TKG

Markers:
AmelogeninX
CSF1PO10
D13S31712,13
D16S53912,13
D18S5115
D21S1128,30
D3S135814,18
D5S81812
D7S8208,10
D8S117910,12
FGA22,25
Penta D11,12
Penta E14,19
TH016,9
TPOX8
vWA18
Web pages https://en.wikipedia.org/wiki/Saos-2_cells
http://www.cells-talk.com/index.php/page/copelibrary?key=SaOS-2
http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-20.html
https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-osteosarcoma-cell-line-saos-2
Publications

PubMed=833871; DOI=10.1093/jnci/58.2.209
Fogh J., Wright W.C., Loveless J.D.
Absence of HeLa cell contamination in 169 cell lines derived from human tumors.
J. Natl. Cancer Inst. 58:209-214(1977)

PubMed=6935474; DOI=10.1093/jnci/66.2.239
Wright W.C., Daniels W.P., Fogh J.
Distinction of seventy-one cultured human tumor cell lines by polymorphic enzyme analysis.
J. Natl. Cancer Inst. 66:239-247(1981)

PubMed=3518877; DOI=10.3109/07357908609038260
Fogh J.
Human tumor lines for cancer research.
Cancer Invest. 4:157-184(1986)

PubMed=3040234
Rodan S.B., Imai Y., Thiede M.A., Wesolowski G., Thompson D., Bar-Shavit Z., Shull S., Mann K., Rodan G.A.
Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties.
Cancer Res. 47:4961-4966(1987)

PubMed=2823272; DOI=10.1073/pnas.84.21.7716
Masuda H., Miller C., Koeffler H.P., Battifora H., Cline M.J.
Rearrangement of the p53 gene in human osteogenic sarcomas.
Proc. Natl. Acad. Sci. U.S.A. 84:7716-7719(1987)

PubMed=8617485; DOI=10.1016/S0046-8177(96)90115-X
Scotlandi K., Serra M., Manara M.C., Benini S., Sarti M., Maurici D., Lollini P.-L., Picci P., Bertoni F., Baldini N.
Immunostaining of the p30/32MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumor.
Hum. Pathol. 27:408-416(1996)

PubMed=12645653; DOI=10.1016/S0165-4608(02)00685-4
Ozaki T., Neumann T., Wai D.H., Schaefer K.-L., van Valen F., Lindner N., Scheel C., Bocker W., Winkelmann W., Dockhorn-Dworniczak B., Horst J., Poremba C.
Chromosomal alterations in osteosarcoma cell lines revealed by comparative genomic hybridization and multicolor karyotyping.
Cancer Genet. Cytogenet. 140:145-152(2003)

PubMed=15150091; DOI=10.1158/0008-5472.CAN-03-0809
Schaefer K.-L., Brachwitz K., Wai D.H., Braun Y., Diallo R., Korsching E., Eisenacher M., Voss R., van Valen F., Baer C., Selle B., Spahn L., Liao S.-K., Lee K.A.W., Hogendoorn P.C.W., Reifenberger G., Gabbert H.E., Poremba C.
Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
Cancer Res. 64:3395-3405(2004)

PubMed=15736406
Pautke C., Schieker M., Tischer T., Kolk A., Neth P., Mutschler W., Milz S.
Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts.
Anticancer Res. 24:3743-3748(2004)

PubMed=15939397; DOI=10.1016/j.bbrc.2005.05.097
Hausser H.-J., Brenner R.E.
Phenotypic instability of Saos-2 cells in long-term culture.
Biochem. Biophys. Res. Commun. 333:216-222(2005)

PubMed=19787792; DOI=10.1002/gcc.20717
Ottaviano L., Schaefer K.-L., Gajewski M., Huckenbeck W., Baldus S., Rogel U., Mackintosh C., de Alava E., Myklebost O., Kresse S.H., Meza-Zepeda L.A., Serra M., Cleton-Jansen A.-M., Hogendoorn P.C.W., Buerger H., Aigner T., Gabbert H.E., Poremba C.
Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort.
Genes Chromosomes Cancer 49:40-51(2010)

PubMed=21519327; DOI=10.1038/labinvest.2011.72
Mohseny A.B., Machado I., Cai Y., Schaefer K.-L., Serra M., Hogendoorn P.C.W., Llombart-Bosch A., Cleton-Jansen A.-M.
Functional characterization of osteosarcoma cell lines provides representative models to study the human disease.
Lab. Invest. 91:1195-1205(2011)

PubMed=23671654; DOI=10.1371/journal.pone.0063056
Lu Y., Soong T.D., Elemento O.
A novel approach for characterizing microsatellite instability in cancer cells.
PLoS ONE 8:E63056-E63056(2013)

PubMed=25031706
Du L., Fan Q.-M., Tu B., Yan W., Tang T.-T.
Establishment and characterization of a new highly metastatic human osteosarcoma cell line derived from Saos2.
Int. J. Clin. Exp. Pathol. 7:2871-2882(2014)

PubMed=26351324; DOI=10.1158/1535-7163.MCT-15-0074
Teicher B.A., Polley E., Kunkel M., Evans D., Silvers T.E., Delosh R.M., Laudeman J., Ogle C., Reinhart R., Selby M., Connelly J., Harris E., Monks A., Morris J.
Sarcoma cell line screen of oncology drugs and investigational agents identifies patterns associated with gene and microRNA expression.
Mol. Cancer Ther. 14:2452-2462(2015)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

Cross-references
Cell line collections ATCC; CRL-7939 - Discontinued
ATCC; HTB-85
BCRJ; 0217
CLS; 300331/p651_SaOS-2
DSMZ; ACC-243
ECACC; 89050205
ICLC; HTL01001
IZSLER; BS TCL 90
KCB; KCB 200550YJ
KCLB; 30085
KCLB; 80023 - Discontinued
NCBI_Iran; C453
RCB; RCB0428
RCB; RCB3688
TKG; TKG 0469
Cell line databases/resources CLDB; cl4250
CLDB; cl4251
CLDB; cl4252
CLDB; cl5281
CCLE; SAOS2_BONE
CCRID; 3111C0001CCC000025
CCRID; 3131C0001000700114
CCRID; 3142C0001000000074
Cosmic-CLP; 909707
GDSC; 909707
LINCS_LDP; LCL-1430
TOKU-E; 3085
Ontologies BTO; BTO:0000971
CLO; CLO_0008947
CLO; CLO_0050140
MCCL; MCC:0000449
Biological sample resources BioSample; SAMN01821594
BioSample; SAMN01821661
BioSample; SAMN03471126
Chemistry resources ChEMBL-Cells; CHEMBL3307737
ChEMBL-Targets; CHEMBL614894
Gene expression databases GEO; GSM170249
GEO; GSM185150
GEO; GSM185151
GEO; GSM320830
GEO; GSM827588
GEO; GSM879222
GEO; GSM1639703
GEO; GSM1639704
GEO; GSM1670401
GEO; GSM1676314
GEO; GSM1701648
Other Wikidata; Q7420876
Polymorphism and mutation databases Cosmic; 687930
Cosmic; 755311
Cosmic; 897500
Cosmic; 909707
Cosmic; 931039
Cosmic; 931912
Cosmic; 1044086
Cosmic; 1044269
Cosmic; 1070841
Cosmic; 1074395
Cosmic; 1082492
Cosmic; 1529898
Cosmic; 1733126
Cosmic; 2301582